Brief: Poxel Announces Presentation Of PXL065 Data

Poxel SA

07/01/2019 07:07

Jan 7 (Reuters) - POXEL SA  POXEL.PA :
    * POXEL ANNOUNCES PRESENTATION OF PXL065 DATA AT THE 2019
NASH-TAG
CONFERENCE
    * DATA OBSERVED SUGGESTS A MORE FAVORABLE PROFILE FOR PXL065
VERSUS PIOGLITAZONE AND OTHER TZDS FOR TREATMENT OF NASH
    * PXL065 IS EXPECTED TO HAVE BENEFICIAL EFFECTS ON
BALLOONING,
INFLAMMATION AND STEATOSIS, WHICH ARE KEY COMPONENTS FOR
TREATING PATIENTS WITH NASH - CEO

Source text for Eikon:  ID:nBw8n3m35a 
Further company coverage:  POXEL.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))